ATX-304 (O-304) is a synthetic pan-AMPK activator characterized by a substituted benzothiadiazole core (CAS 1261289-04-6). Developed as a high-purity reference standard for metabolic signaling research, kinase binding assays, and AMPK-pathway investigation. Assay purity >98% (HPLC verified). For research use only — not for human consumption.
$85.00
43 in stock
ATX-304 (O-304) is a synthetic small-molecule research compound engineered as a potent, pan-activator of AMP-activated protein kinase (AMPK) — the master regulator of cellular energy homeostasis. Characterized by a substituted benzothiadiazole core (CAS 1261289-04-6), it is designed for high-precision investigation of AMPK-dependent signaling, intracellular energy metabolism, and kinase-ligand binding dynamics in laboratory settings.
Originally developed by researchers at Umeå University and Betagenon AB in Sweden, ATX-304 has advanced to Phase 2 clinical investigation in obesity and cardiometabolic disease — making it one of the most clinically relevant AMPK-targeted research compounds available today.
Technical Specifications
Mechanism of Action
ATX-304 acts as a selective allosteric activator across all three AMPK heterotrimeric complexes. Its benzothiadiazole scaffold binds to the catalytic domain of AMPK, stabilizing the active enzyme conformation and driving downstream phosphorylation of key metabolic targets including ACC, HMGCR, and TSC2. This allows researchers to study glucose and lipid oxidation regulation, mitochondrial biogenesis signaling, and energy-sensing pathway dynamics in isolated cellular systems.
Research Applications
Storage & Handling
Disclaimer: ATX-304 is sold exclusively for laboratory research use. It is not an FDA-approved drug, dietary supplement, or medical treatment, and is strictly prohibited for human or animal consumption. For research purposes only.
Only logged in customers who have purchased this product may leave a review.
$79.00 Original price was: $79.00.$39.99Current price is: $39.99.
Reviews
There are no reviews yet.